StoryFunding
Samsung Electronics leads Element Biosciences' $175M Series E, becomes largest shareholder
Samsung Electronics led an upsized $175M Series E for Element Biosciences, becoming the company's largest shareholder. The funding will accelerate adoption of AVITI, VITARI, and upcoming launches including AVITI Dx and tissue profiling capabilities. Samsung's investment signals confidence in Element as a long-term strategic partner in precision genomics.